Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CGTX
CGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CGTX News
Cognition Extends Expanded Access Program for DLB
Feb 05 2026
Newsfilter
Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise
Dec 17 2025
NASDAQ.COM
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO
Nov 26 2025
NASDAQ.COM
HC Wainwright & Co. Affirms Buy Rating for Cognition Therapeutics, Keeps $3 Price Target Intact
Nov 19 2025
Benzinga
Cognition Therapeutics Finishes Participant Enrollment for Phase 2 Trial of Zervimesine (CT1812) in Early Alzheimer's Disease
Nov 13 2025
Newsfilter
CGTX, RVPH, SHOT, SONN, AKTX Surge in After-Hours Trading Following Clinical Developments and Fed Rate Cut Expectations
Sep 18 2025
NASDAQ.COM
Biotech Stocks Surge After Hours Due to Trial Advancements, Funding Developments, and Anticipated Milestones
Sep 17 2025
NASDAQ.COM
Monday's Underperforming Sectors: General Contractors & Builders, Pharmaceuticals
Sep 15 2025
NASDAQ.COM
Cognition Therapeutics Achieves 75% Enrollment Goal for Zervimesine (CT1812) Study in Early Alzheimer's Disease
Sep 03 2025
Newsfilter
The 5 Best-Performing Stocks in the Nasdaq Composite for August 2025
Sep 03 2025
NASDAQ.COM
Snowflake Shares Surge 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 28 2025
Benzinga
Cognition Therapeutics Initiates $30 Million Stock Offering
Aug 28 2025
SeekingAlpha
Cognition Therapeutics Meets Nasdaq Compliance for $1.00 Bid Price Requirement
Aug 26 2025
SeekingAlpha
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Aug 13 2025
Benzinga
Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug
Aug 13 2025
Benzinga
Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer's Disease
Jul 29 2025
Newsfilter
Show More News
